Skip to main content
SpringerLink
Log in

Tocilizumab

Toxic erythema and eosinophilia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sernicola A, et al. "Toxic erythema" and eosinophilia associated with tocilizumab therapy in a COVID-19 patient. Journal of the European Academy of Dermatology and Venereology 34: e368-e370, No. 8, Aug 2020. Available from: URL: http://doi.org/10.1111/jdv.16620

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tocilizumab. Reactions Weekly 1821, 225 (2020). https://doi.org/10.1007/s40278-020-83345-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-83345-2

Search

Navigation